Christophe Gobert-Gut

Brest, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Brest, FR 

Overview

Christophe Gobert-Gut practices in Brest, France. His top areas of expertise are Pulmonary Embolism, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Chronic Obstructive Pulmonary Disease (COPD), and Endoscopy.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Brest, France
Other Locations
Hôpital Cochin Port Royal, APHP
Paris, France
42055, France
42055 St Étienne Cedex 2, Saint-etienne, 42055, France
Morlaix, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Impact on Quality of Life with Pulmonary RehAbilitation After Pulmonary EMBOlism: RAMBO Study
Impact on Quality of Life with Pulmonary RehAbilitation After Pulmonary EMBOlism: RAMBO Study
Enrollment Status: Recruiting
Publish Date: December 16, 2024
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of Non-Invasive Ventilation Preoperative Lung Resection Surgery
Evaluation of Non-Invasive Ventilation Preoperative Lung Resection Surgery
Enrollment Status: Completed
Publish Date: December 03, 2025
Intervention Type: Device
Study Phase: Not Applicable
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Efficacy of Clarithromycin or Moxifloxacin Containing Regimen in 6 Months Sputum Conversion of Mycobacterium Xenopi
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Mepolizumab 100 mg SC as add-on Treatment in Participants With COPD Experiencing Frequent Exacerbations and Characterized by Eosinophil Levels (Study 208657)
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Biological
Study Drug: Mepolizumab
Study Phase: Phase 3
Zephyr Etude Post-Inscription (French Registry)
Zephyr Etude Post-Inscription (French Registry)
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Device
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Enrollment Status: Completed
Publish Date: August 25, 2022
Intervention Type: Other
Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -
Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB -
Enrollment Status: Terminated
Publish Date: July 11, 2022
Intervention Type: Other
Study Phase: Not Applicable
Frequency and Risk Factors of the Lung High Blood Pressure Post-embolique in the Fall of a First Episode of Idiopathic Pulmonary Embolism. Study PADIS HTP
Frequency and Risk Factors of the Lung High Blood Pressure Post-embolique in the Fall of a First Episode of Idiopathic Pulmonary Embolism. Study PADIS HTP
Enrollment Status: Terminated
Publish Date: July 20, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 9 Less Clinical Trials

26 Total Publications

Proximal pulmonary artery wall shear stress derived from computational fluid dynamics: A noninvasive biomarker for CTEPH and perfusion mismatch.
Proximal pulmonary artery wall shear stress derived from computational fluid dynamics: A noninvasive biomarker for CTEPH and perfusion mismatch.
Journal: Physiological reports
Published: September 30, 2025

Frequently Asked Questions about Christophe Gobert-Gut

Is Christophe Gobert-Gut a top-rated expert for Pulmonary Embolism?

MediFind is an objective health platform that identifies experts based on real-world data. Christophe Gobert-Gut is classified as an Experienced expert for Pulmonary Embolism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christophe Gobert-Gut participate in research or clinical trials?

Yes. Christophe Gobert-Gut has published 26 articles and abstracts on conditions like Pulmonary Embolism. You can view a list of Christophe Gobert-Gut's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gobert-Gut's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile